<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03705013</url>
  </required_header>
  <id_info>
    <org_study_id>2018-09</org_study_id>
    <nct_id>NCT03705013</nct_id>
  </id_info>
  <brief_title>Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)</brief_title>
  <official_title>Observational Study of Sub-populations From &quot;A Longitudinal Study of Cologuard in an Average Risk Population Assessing a Three Year Test Interval&quot;/Protocol 2014-01 Post-Approval Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Exact Sciences Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Exact Sciences Corporation</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary endpoint is to obtain longitudinal information on four sub-populations from the
      Cologuard Post-Approval Study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects who consented to enroll in Exact Sciences Protocol 2014-01, that fit one of the
      following sub-populations, will be asked to participate in the sub-study. Population 1
      includes those whose Cologuard T0 result was positive and colonoscopy result was negative.
      Population 2 includes those whose Cologuard T0 result was positive and subject declined to
      complete a colonoscopy per protocol. Population 3 includes those whose Cologuard result at T3
      was positive and colonoscopy result at T3 was negative. Population 4 includes those whose
      Cologuard result at T3 was positive and subject declined to complete a colonoscopy per
      protocol. Subjects that enrolled in the Exact Sciences Protocol 2014-01, who provided written
      informed consent to participate in this sub-study, will asked to complete the Follow-Up
      Questionnaire during a phone interview.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Sponsor Decision
  </why_stopped>
  <start_date type="Actual">October 30, 2018</start_date>
  <completion_date type="Actual">November 16, 2019</completion_date>
  <primary_completion_date type="Actual">November 16, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The number of subjects with discordant results that can be attributed to intercurrent disease</measure>
    <time_frame>3 years after positive Cologuard result</time_frame>
    <description>A medical chart review and phone interview will be conducted for each subject. The Follow-Up Questionnaire will be completed during the phone interview.</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">51</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Baseline Cologuard positive and negative colonoscopy</arm_group_label>
    <description>Those whose Cologuard T0 result was positive and colonoscopy result was negative.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Baseline Cologuard positive and no colonoscopy</arm_group_label>
    <description>Those whose Cologuard T0 result was positive and subject declined to complete a colonoscopy per protocol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3-year follow-up Cologuard positive and negative colonoscopy</arm_group_label>
    <description>Those whose Cologuard result at T3 was positive and colonoscopy result at T3 was negative.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3-year follow-up Cologuard positive and no colonoscopy</arm_group_label>
    <description>Those whose Cologuard result at T3 was positive and subject declined to complete a colonoscopy per protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cologuard</intervention_name>
    <description>Observational</description>
    <arm_group_label>3-year follow-up Cologuard positive and negative colonoscopy</arm_group_label>
    <arm_group_label>3-year follow-up Cologuard positive and no colonoscopy</arm_group_label>
    <arm_group_label>Baseline Cologuard positive and negative colonoscopy</arm_group_label>
    <arm_group_label>Baseline Cologuard positive and no colonoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        There are four sub-populations of the Cologuard Post-Approval Study (2014-01) under
        observation: positive first Cologuard test and negative colonoscopy or no colonoscopy and
        positive 3-year follow-up Cologuard test and negative colonoscopy or no colonoscopy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject falls into one of the 4 sub-populations

          -  Willing to provide informed consent

        Exclusion Criteria:

          -  Death

          -  Investigator/sponsor decision

          -  Subject withdrew consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Thomas C Lenzmeier, M.D., P.C.</name>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Arizona Medical Associates, PC</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <zip>85206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fiel Family and Sports Medicine, PC</name>
      <address>
        <city>Tempe</city>
        <state>Arizona</state>
        <zip>85206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cassidy Medical Group</name>
      <address>
        <city>Carlsbad</city>
        <state>California</state>
        <zip>92008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John D. Homan, MD</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Desert Oasis Healthcare Medical Group</name>
      <address>
        <city>Palm Springs</city>
        <state>California</state>
        <zip>92262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Innovative Research of West Florida</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Homestead Medical Research</name>
      <address>
        <city>Homestead</city>
        <state>Florida</state>
        <zip>33030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Awareness Inc., Jupiter</name>
      <address>
        <city>Jupiter</city>
        <state>Florida</state>
        <zip>33458</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Awareness Inc., Port St. Lucie</name>
      <address>
        <city>Port Saint Lucie</city>
        <state>Florida</state>
        <zip>34984</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Kaufmann Clinic</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University, Eskanazi Hospital, Regenstrief Health Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centennial Medical Group</name>
      <address>
        <city>Elkridge</city>
        <state>Maryland</state>
        <zip>21075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nevada Family Care</name>
      <address>
        <city>Henderson</city>
        <state>Nevada</state>
        <zip>89074</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina, Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Practice Center of Wooster</name>
      <address>
        <city>Massillon</city>
        <state>Ohio</state>
        <zip>44647</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Regional Clinic</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78759</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PCP for Life</name>
      <address>
        <city>Montgomery</city>
        <state>Texas</state>
        <zip>77356</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wasatch Clinical Research</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>September 24, 2018</study_first_submitted>
  <study_first_submitted_qc>October 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2018</study_first_posted>
  <last_update_submitted>April 10, 2020</last_update_submitted>
  <last_update_submitted_qc>April 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cologuard</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

